New Delhi, Sep 3 (IANS) Finerenone — a medication used to reduce the risk of kidney function decline — can lower death risk and boost survival in patients with heart failure, which impacts more than 60 million people globally, according to a study.
The gradual loss of the heart’s capacity to pump and fill with blood is known as heart failure. With no choices for treatment, around half of all heart failure patients have modestly diminished or retained left ventricular ejection fraction.
The study by Brigham and Women’s Hospital in the US pointed out finerenone, a non-steroidal mineralocorticoid receptor antagonist, as a potential new treatment option for patients. Finerenone is also used to treat chronic kidney disease (CKD) in patients with type 2 diabetes.
Principal investigator and corresponding author Scott Solomon, at Mass General Brigham noted that the drug represents a new drug class that may become a pillar of therapy for this disease.
The team conducted an international-level clinical trial by dividing over 6,000 patients into two groups — the group that used Finerenone and the placebo group.
The finerenone group experienced fewer heart failure episodes and cardiovascular deaths (842) than the placebo group (1,024).
The percentage of patients who died from cardiovascular causes was 8.1 per cent and 8.7 per cent.
Finerenone was also associated with an increased risk of hyperkalemia — too much potassium in the blood — and a reduced risk of hypokalemia — lower than normal potassium levels in the blood.
Solomon noted that benefits were seen among patients receiving other approved therapies as well as regardless of the ejection percentage.
The results were concurrently published in the New England Journal of Medicine and presented at the European Society of Cardiology Congress in 2024.
–IANS
ts/rvt
Disclaimer
The information contained in this website is for general information purposes only. The information is provided by TodayIndia.news and while we endeavour to keep the information up to date and correct, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.
In no event will we be liable for any loss or damage including without limitation, indirect or consequential loss or damage, or any loss or damage whatsoever arising from loss of data or profits arising out of, or in connection with, the use of this website.
Through this website you are able to link to other websites which are not under the control of TodayIndia.news We have no control over the nature, content and availability of those sites. The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.
Every effort is made to keep the website up and running smoothly. However, TodayIndia.news takes no responsibility for, and will not be liable for, the website being temporarily unavailable due to technical issues beyond our control.
For any legal details or query please visit original source link given with news or click on Go to Source.
Our translation service aims to offer the most accurate translation possible and we rarely experience any issues with news post. However, as the translation is carried out by third part tool there is a possibility for error to cause the occasional inaccuracy. We therefore require you to accept this disclaimer before confirming any translation news with us.
If you are not willing to accept this disclaimer then we recommend reading news post in its original language.
